New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis
Franco Frati,1 Lorenzo Cecchi,2,3 Enrico Scala,4 Erminia Ridolo,5 Ilaria Dell'Albani,1 Eleni Makrì,6 Giovanni Pajno,7 Cristoforo Incorvaia6 1Medical and Scientific Department, Stallergenes, Milan, Italy; 2Interdepartmental Centre of Bioclimatology, University of Florence, Florenc...
Saved in:
Main Authors: | Frati F, Cecchi L, Scala E, Ridolo E, Dell'Albani I, Makrì E, Pajno G, Incorvaia C |
---|---|
Format: | article |
Language: | EN |
Published: |
Dove Medical Press
2014
|
Subjects: | |
Online Access: | https://doaj.org/article/ac21c935e5bc48b2a71bbabcfaa02d42 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
New product development with the innovative biomolecular sublingual immunotherapy formulations for the management of allergic rhinitis [Corrigendum]
by: Frati F, et al.
Published: (2015) -
Sublingual immunotherapy increases Treg/Th17 ratio in allergic rhinitis
by: Wang Jiarong, et al.
Published: (2021) -
Sublingual house dust mite immunotherapy has no impact on decrease of circulating erythrocytes upon airway allergen challenge in allergic rhinitis
by: Galateja Jordakieva, et al.
Published: (2017) -
Preference for Immunotherapy with Tablets by People with Allergic Rhinitis
by: Tankersley M, et al.
Published: (2021) -
Rupatadine to prevent local allergic reactions to sublingual allergy immunotherapy: a case series
by: Anne K. Ellis, et al.
Published: (2021)